Precision medicine for cancer with next-generation functional diagnostics

Friedman, Adam A., Letai, Anthony, Fisher, David E., Flaherty, Keith T.·2015·Nature Reviews Cancer

DOI 10.1038/nrc4015

Cited by (571)

Items 101–200 of 571

Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy
F. Niu, Jin Yan, Bohan Ma, Shichao Li, Yongping Shao, Pengcheng He, Wanggang Zhang, Wangxiao He, Peter X. Ma, Wuyuan Lu · 2018 · Biomaterials
3D microgroove electrical impedance sensing to examine 3D cell cultures for antineoplastic drug assessment
Yuxiang Pan, Deming Jiang, Chenlei Gu, Yong Long Qiu, Hao Wan, Ping Wang · 2020 · Microsystems & Nanoengineering
Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study
Lars Henrik Jensen, Sílvia Regina Rogatto, Jan Lindebjerg, Birgitte Mayland Havelund, Cecilie Abildgaard, Luísa Matos do Canto, Chris Vagn-Hansen, Claus Dam, Søren Rafael Rafaelsen, Torben Frøstrup Hansen · 2023 · Journal of Experimental & Clinical Cancer Research
Cellular Metabolic Heterogeneity In Vivo Is Recapitulated in Tumor Organoids
Joe T. Sharick, Justin J. Jeffery, Mohammad R. Karim, Christine M. Walsh, Karla Esbona, Rebecca S. Cook, Melissa C. Skala · 2019 · Neoplasia
Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining “Actionability” of a Molecular Lesion and Patient Management Support
Chae, Young Kwang, Pan, Alan P., Davis, Andrew A., Patel, Sandip P., Carneiro, Benedito A., Kurzrock, Razelle, Giles, Francis J. · 2017 · Molecular Cancer Therapeutics
Probing the biological obstacles of nanomedicine with gold nanoparticles
Bin Li, Lucas A. Lane · 2018 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
TGSA: protein–protein association-based twin graph neural networks for drug response prediction with similarity augmentation
Yiheng Zhu, Zhenqiu Ouyang, Wenbo Chen, Ruiwei Feng, Danny Z. Chen, Ji Cao, Jian Wu · 2021 · Bioinformatics
Electrophysiology-based stratification of pancreatic tumorigenicity by label-free single-cell impedance cytometry
John S. McGrath, Carlos Honrado, John H. Moore, Sara J. Adair, Walter B. Varhue, Armita Salahi, Vahid Farmehini, Bernadette J. Goudreau, Sarbajeet Nagdas, Edik Matthew Blais et al. · 2019 · Analytica Chimica Acta
Bioinformatics for Cancer Immunotherapy
Christoph Holtsträter, Barbara Schrörs, Thomas Bukur, Martin Löwer · 2020 · Methods in molecular biology
Optimizing mouse models for precision cancer prevention
Clémentine Le Magnen, Aditya Dutta, Cory T. Abate-Shen · 2016 · Nature reviews. Cancer
Automated biophysical classification of apoptotic pancreatic cancer cell subpopulations by using machine learning approaches with impedance cytometry
Carlos Honrado, Armita Salahi, Sara J. Adair, John H. Moore, Todd W. Bauer, Nathan S. Swami · 2022 · Lab on a Chip
How to unleash mitochondrial apoptotic blockades to kill cancers?
Jing Deng · 2016 · Acta Pharmaceutica Sinica B
Intelligent whole-blood imaging flow cytometry for simple, rapid, and cost-effective drug-susceptibility testing of leukemia
Hirofumi Kobayashi, Cheng Lei, Yi Wu, Chun‐Jung Huang, Atsushi Yasumoto, Masahiro Jona, Wenxuan Li, Yunzhao Wu, Yaxiaer Yalikun, Yiyue Jiang et al. · 2019 · Lab on a Chip
Precision oncology: transforming cancer care through personalized medicine
Rituraj, Rashmi Saxena Pal, Jenny Wahlang, Yogendra Pal, MVNL Chaitanya, Sumedha Saxena · 2025 · Medical Oncology
Addressing the challenges of applying precision oncology
Seung Ho Shin, Ann M. Bode, Zigang Dong · 2017 · npj Precision Oncology
The novel long intergenic noncoding RNA UCC promotes colorectal cancer progression by sponging miR-143
Fengting Huang, Wen‐Ying Chen, Zhiqiang Gu, Yanyan Zhuang, Chu-Qiang Li, Lingyun Wang, Juanfei Peng, Zhe Zhu, Xin Luo, Yuanhua Li et al. · 2017 · Cell Death and Disease
The 10,000 Immunomes Project: Building a Resource for Human Immunology
Kelly A. Zalocusky, Matthew J. Kan, Zicheng Hu, Patrick Dunn, Elizabeth Thomson, Jeffrey A. Wiser, Sanchita Bhattacharya, Atul Janardhan Butte · 2018 · Cell Reports
A User-Friendly, Web-Based Integrative Tool (ESurv) for Survival Analysis: Development and Validation Study
Kyoungjune Pak, Sae‐Ock Oh, Tae Sik Goh, Hye Jin Heo, Myoung‐Eun Han, Dae Cheon Jeong, Chi‐Seung Lee, Hokeun Sun, Junho Kang, Suji Choi et al. · 2020 · Journal of Medical Internet Research
Formalin-fixed paraffin-embedded sample conditions for deep next generation sequencing
Masayuki Nagahashi, Yoshifumi Shimada, Hiroshi Ichikawa, Satoru Nakagawa, Nobuaki Sato, Koji Kaneko, Keiichi Homma, Takashi Kawasaki, Keisuke Kodama, Stephen R. Lyle et al. · 2017 · Journal of Surgical Research
Conditional reprogramming: next generation cell culture
Xiaoxiao Wu, Shengpeng Wang, Mingxing Li, Jing Li, Jing Shen, Yueshui Zhao, Jun Pang, Qinglian Wen, Meijuan Chen, Bin Wei et al. · 2020 · Acta Pharmaceutica Sinica B
VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer
Yinglong Zhang, He Shen, Henry G. Withers, Nuo Yang, Kayla E. Denson, Ashley L. Mussell, Alexander M. Truskinovsky, Qingyu Fan, Irwin H. Gelman, Costa G. Frangou et al. · 2017 · Scientific Reports
Utilization of optically induced dielectrophoresis in a microfluidic system for sorting and isolation of cells with varied degree of viability: Demonstration of the sorting and isolation of drug-treated cancer cells with various degrees of anti-cancer drug resistance gene expression
Po-Yu Chu, Chia‐Jung Liao, Chia‐Hsun Hsieh, Hung‐Ming Wang, Wen-Pin Chou, Ping‐Hei Chen, Min‐Hsien Wu · 2018 · Sensors and Actuators B Chemical
Study of pharmacogenomic information in FDA-approved drug labeling to facilitate application of precision medicine
Darshan Mehta, Ryley Uber, Taylor M. Ingle, Catherine Li, Zhichao Liu, Shraddha Thakkar, Baitang Ning, Leihong Wu, Junshuang Yang, Steve Harris et al. · 2020 · Drug Discovery Today
Paradigms for Precision Medicine in Epichaperome Cancer Therapy
Nagavarakishore Pillarsetty, Komal L. Jhaveri, Tony Taldone, Eloisi Caldas-Lopes, Blesida J. Punzalan, Suhasini Joshi, Alexander Bolaender, Mohammad M. Uddin, Anna Rodina, Pengrong Yan et al. · 2019 · Cancer Cell
Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin
Robert Alan Nagourney, Steven Scott Evans, Peter H. Tran, Adam J. Nagourney, Paul Hendrick Sugarbaker · 2020 · European Journal of Surgical Oncology
Translocation-Related Sarcomas
Kenji Nakano, Shunji Takahashi · 2018 · International Journal of Molecular Sciences
Recent advances in microfluidic technology and applications for anti-cancer drug screening
Yiwei Shi, Ying Cai, Yuhong Cao, Zhanying Hong, Yifeng Chai · 2020 · TrAC Trends in Analytical Chemistry
Multiparametric quantitative phase imaging for real-time, single cell, drug screening in breast cancer
Edward R. Polanco, Tarek E. Moustafa, Andrew Butterfield, Sandra D. Scherer, Emilio Cortes-Sanchez, Tyler Andrew Bodily, Benjamin T. Spike, Bryan E. Welm, Philip Seth Bernard, Thomas A. Zangle · 2022 · Communications Biology
A network modeling approach to elucidate drug resistance mechanisms and predict combinatorial drug treatments in breast cancer
Jorge Gómez Tejeda Zañudo, Maurizio Scaltriti, Réka Albert · 2017 · Cancer Convergence
Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence
Xingwu Zhou, Moyuan Qu, Peyton J. Tebon, Xing Jiang, Canran Wang, Yumeng Xue, Jixiang Zhu, Shiming Zhang, Rahmi Öklü, Shiladitya Sengupta et al. · 2020 · Advanced Science
Precision medicine in heritable cancer: when somatic tumour testing and germline mutations meet
Joanne Yuen Yie Ngeow, Charis Eng · 2016 · npj Genomic Medicine
Profiling DNA mutation patterns by SERS fingerprinting for supervised cancer classification
Lei Wu, Alexandra Teixeira, Alejandro Garrido‐Maestu, Laura Muinelo‐Romay, Luís Lima, Lúcio Lara Santos, Marta Prado, Lorena Diéguez · 2020 · Biosensors and Bioelectronics
Personalized Cancer Models for Target Discovery and Precision Medicine
Carla Grandori, Christopher J. Kemp · 2018 · Trends in cancer
Pharmacotherapeutic Strategies and New Targets in OCD
Christopher Pittenger · 2021 · Current topics in behavioral neurosciences
Emerging Opportunities for Target Discovery in Rare Cancers
Tanaz Sharifnia, Andrew Lee Hong, Corrie Painter, Jesse S. Boehm · 2017 · Cell chemical biology
A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS–Driven Lung Cancer
Hongchen Cai, Su Kit Chew, Chuan Li, Min K. Tsai, Laura Andrejka, Christopher W. Murray, Nicholas W. Hughes, Emily G. Shuldiner, Emily L. Ashkin, Rui Tang et al. · 2021 · Cancer Discovery
Magnetically Actuated Protease Sensors for in Vivo Tumor Profiling
Simone Schuerle, Jaideep S. Dudani, Michael G. Christiansen, Polina Anikeeva, Sangeeta N. Bhatia · 2016 · Nano Letters
Fluorescence in situ hybridization in surgical pathology: principles and applications
Liang Cheng C, Shaobo Zhang, Lisha Wang, Gregory T. MacLennan, Darrell D. Davidson · 2017 · The Journal of Pathology Clinical Research
Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation
Arif E. Çetin, Mark M. Stevens, Nicholas L. Calistri, Mariateresa Fulciniti, Selim Olçum, Robert J. Kimmerling, Nikhil C. Munshi, Scott R. Manalis · 2017 · Nature Communications
Tissue-based next generation sequencing: application in a universal healthcare system
Seán O. Hynes, Brendan Pang, Jacqueline A. James, Perry Maxwell, Manuel Salto‐Tellez · 2017 · British Journal of Cancer
Toward Precision Healthcare: Context and Mathematical Challenges
C. Colijn, Nick S. Jones, Iain G. Johnston, S. Yaliraki, Mauricio Barahona · 2017 · Frontiers in Physiology
Targeting TANK-binding kinase 1 (TBK1) in cancer
Or‐Yam Revach, Shuming Liu, Russell William Jenkins · 2020 · Expert Opinion on Therapeutic Targets
Regulation of Long Non-Coding RNAs by Plant Secondary Metabolites: A Novel Anticancer Therapeutic Approach
Mohammad Reza Kalhori, Hamid Khodayari, Saeed Khodayari, Miko Vesovic, Gloria Jackson, Mohammad Hosein Farzaei, Anupam Bishayee · 2021 · Cancers
Functional profiling of venetoclax sensitivity can predict clinical response in multiple myeloma
Shannon M. Matulis, Vikas Anand Gupta, Paola E. Neri, Nizar Jacques Bahlis, Paulo Maciag, Joel D. Leverson, Leonard T. Heffner, Sagar Lonial, Ajay K. Nooka, Jonathan L. Kaufman et al. · 2019 · Leukemia
An automated microfluidic gene-editing platform for deciphering cancer genes
Hugo Sinha, Angela B. V. Quach, Philippe Q. N. Vo, Steve C. C. Shih · 2018 · Lab on a Chip
Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer
Yuanhui Lai, Jian Chen, Xiaoping Wang, Yanqing Wu, Haitao Peng, Xiaohong Lin, Wenjian Wang · 2017 · Journal of Experimental & Clinical Cancer Research
In vitro and in vivo drug screens of tumor cells identify novel therapies for high‐risk child cancer
Loretta M. S. Lau, Chelsea Mayoh, Jinhan Xie, Paulette Barahona, Karen L. MacKenzie, Marie Wong, Alvin Kamili, Maria Tsoli, Timothy W. Failes, Amit Kumar et al. · 2021 · EMBO Molecular Medicine
SparkText: Biomedical Text Mining on Big Data Framework
Zhan Ye, Ahmad Pahlavan Tafti, Karen He, Kai Wang, Max M. He · 2016 · PLoS ONE
Molecular and Genomic Determinants of Response to Immune Checkpoint Inhibition in Cancer
Russell William Jenkins, Rohit Thummalapalli, Jacob Carter, Israel Cañadas, David Allen Barbie · 2017 · Annual Review of Medicine
Chemotherapeutic drug–DNA hybrid nanostructures for anti-tumor therapy
Xiangang Huang, Nicholas Thomas Blum, Jing Lin, Jinjun Shi, Chuan Zhang, Peng Huang · 2020 · Materials Horizons
Translation Potential and Challenges of In Vitro and Murine Models in Cancer Clinic
Yuan Long, Bin Xie, Hong C. Shen, Danyi Wen · 2022 · Cells
Recent advances in 3D bioprinted neural models: A systematic review on the applications to drug discovery
Amanda Orr, Farnoosh Kalantarnia, Shama Nazir, Behzad Bolandi, Dominic Alderson, Kerrin O’Grady, Mina Hoorfar, Lisa M. Julian, Stephanie Michelle Willerth · 2025 · Advanced Drug Delivery Reviews
Organoid technology and applications in cancer immunotherapy and precision medicine
Krisztián Homicskó · 2020 · Current Opinion in Biotechnology
Aptamers targeting protein-specific glycosylation in tumor biomarkers: general selection, characterization and structural modeling
Ana Díaz‐Fernández, Rebeca Miranda‐Castro, Natalia Díaz, Dimas Suárez, Noemı́ de-los-Santos-Álvarez, Marı́a Jesús Lobo-Castañón · 2020 · Chemical Science
Organotypic primary blood vessel models of clear cell renal cell carcinoma for single-patient clinical trials
Virumbrales-Muñoz, María, Chen, Jiong, Ayuso, Jose, Lee, Moonhee, Abel, E. Jason, Beebe, David J. · 2020 · Lab on a Chip
Changing paradigm of cancer therapy: precision medicine by next-generation sequencing
Yuan Chao Xue, Yuan Chao Xue, William Ross Wilcox, William Ross Wilcox · 2016 · Cancer Biology and Medicine
Cancer metabolism gets physical
Peter F. DelNero, Benjamin David Hopkins, Lewis C. Cantley, Claudia Fischbach · 2018 · Science Translational Medicine
Biomaterial Scaffolds Recruit an Aggressive Population of Metastatic Tumor Cells In Vivo
Grace G. Bushnell, Tejaswini P. Hardas, Rachel M. Hartfield, Yining Zhang, Robert S. Oakes, Scott Ronquist, Haiming Chen, Indika Rajapakse, Max S. Wicha, Jacqueline Sara Jeruss et al. · 2019 · Cancer Research
Effects of culture method on response to EGFR therapy in head and neck squamous cell carcinoma cells
José María Ayuso, Ross A. Vitek, Adam D. Swick, Melissa C. Skala, Kari Braun Wisinski, Randall J. Kimple, Paul F. Lambert, David J. Beebe · 2019 · Scientific Reports
Immunotherapy for non-small cell lung cancer (NSCLC), as a stand-alone and in combination therapy
Jasmine Kaur, Jackson Elms, Alan L. Munn, David M. Good, Ming Qian Wei · 2021 · Critical Reviews in Oncology/Hematology
Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders
David Gurwitz · 2016 · Dialogues in Clinical Neuroscience
2D- and 3D-Based Intestinal Stem Cell Cultures for Personalized Medicine
Liu, Yuan, Chen, Ye-Guang · 2018 · Cells
To target the untargetable: elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia
David Andrew Sallman · 2020 · Haematologica
CaliPro: A Calibration Protocol That Utilizes Parameter Density Estimation to Explore Parameter Space and Calibrate Complex Biological Models
Louis R. Joslyn, Denise E. Kirschner, Jennifer J. Linderman · 2020 · Cellular and Molecular Bioengineering
Cellular Senescence in Immunity against Infections
Veronica Marrella, Amanda Facoetti, Barbara Cassani · 2022 · International Journal of Molecular Sciences
Zebrafish Cancer Avatars: A Translational Platform for Analyzing Tumor Heterogeneity and Predicting Patient Outcomes
Majd A. Al‐Hamaly, Logan T. Turner, Angelica Rivera-Martinez, Analiz Rodriguez, Jessica S. Blackburn · 2023 · International Journal of Molecular Sciences
Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere models
Max A. Stockslager, Seth W. Malinowski, Mehdi Touat, Jennifer C. Yoon, Jack E. Geduldig, Mahnoor Mirza, Annette S. Kim, Patrick Yung Wen, Kin-Hoe Chow, Keith Lloyd Ligon et al. · 2021 · Cell Reports
Patient Derived Organoids (PDOs), Extracellular Matrix (ECM), Tumor Microenvironment (TME) and Drug Screening: State of the Art and Clinical Implications of Ovarian Cancer Organoids in the Era of Precision Medicine
Giulia Spagnol, Francesca Sensi, Orazio De Tommasi, Matteo Marchetti, Giulio Bonaldo, Livia Xhindoli, Marco Noventa, Marco Agostini, Roberto Tozzi, Carlo Saccardi · 2023 · Cancers
Machine Learning and Health Science Research: Tutorial
Hunyong Cho, Jane She, Daniel de Marchi, Helal El-Zaatari, Edward L. Barnes, Anna R. Kahkoska, Michael R. Kosorok, Arti Virkud · 2023 · Journal of Medical Internet Research
Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma
Yock Ping Chow, Lu Ping Tan, San Jiun Chai, Norazlin Abdul Aziz, Siew Woh Choo, Paul V.H. Lim, Pathmanathan Rajadurai, Noor Kaslina Mohd Kornain, Chee Lun Lum, Kin Choo Pua et al. · 2017 · Scientific Reports
Hyperpolarized Amino Acid Derivatives as Multivalent Magnetic Resonance pH Sensor Molecules
Christian Hundshammer, Stephan Düwel, David Ruseckas, Geoffrey J. Topping, Piotr Dzien, Christoph A. Müller, Benedikt Feuerecker, Jan‐Bernd Hövener, Axel Haase, Markus Schwaiger et al. · 2018 · Sensors
A normalized drug response metric improves accuracy and consistency of anticancer drug sensitivity quantification in cell-based screening
Abhishekh Gupta, Prson Gautam, Krister Wennerberg, Tero A. Aittokallio · 2020 · Communications Biology
Self-aligned sequential lateral field non-uniformities over channel depth for high throughput dielectrophoretic cell deflection
Xuhai Huang, Karina Torres‐Castro, Walter B. Varhue, Armita Salahi, Rasin Ahmed, Carlos Honrado, Audrey C. Brown, Jennifer L. Güler, Nathan S. Swami · 2021 · Lab on a Chip
Targeting tropomyosin receptor kinase for cancer therapy
Qi Miao, Kun Ma, Dong Chen, Xiaoxing Wu, Sheng Jiang · 2019 · European Journal of Medicinal Chemistry
Emerging liver organoid platforms and technologies
Do Thuy Uyen Ha Lam, Yock Young Dan, Yun-Shen Chan, Huck‐Hui Ng · 2021 · Cell Regeneration
Precision or Personalized Medicine for Cancer Chemotherapy: Is there a Role for Herbal Medicine
Zhijun Kevin Wang, Xuefeng Liu, Rebecca Ho, Christopher Wai Kei Lam, Moses Chow · 2016 · Molecules
Genetic profiling of intrahepatic cholangiocarcinoma and its clinical implication in targeted therapy.
Diyang Xie, Zhenggang Ren, Jia Fan, Qiang Gao · 2016 · PubMed Central
Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience
Longrong Wang, Hongxu Zhu, Yiming Zhao, Qi Pan, Anrong Mao, Weiping Zhu, Ning Zhang, Zhenhai Lin, Jiamin Zhou, Yilin Wang et al. · 2020 · Journal of Translational Medicine
Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks
Ishwar N. Kohale, Danielle M. Burgenske, Ann C. Mladek, Katrina K. Bakken, Jenevieve Kuang, Judy Caroline Boughey, Liewei Wang, Jodi M. Carter, Eric B. Haura, Matthew Philip Goetz et al. · 2021 · Cancer Research
Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors
Jhin Jieh Lim, Lissa Hooi, Yock Young Dan, Glenn Kunnath Bonney, Lei Zhou, Pierce K. H. Chow, Cheng Ean Chee, Tan Boon Toh, Edward Kai‐Hua Chow · 2022 · Journal of Experimental & Clinical Cancer Research
Rise of precision medicine: can it deliver on its promise in IBD?
Stefan Schreiber, Konrad Aden, Florian Tran, Philip C Rosenstiel · 2025 · Gut
Genomics-guided pre-clinical development of cancer therapies
Hayley E. Francies, Ultan McDermott, Mathew J. Garnett · 2020 · Nature Cancer
The Progress and Clinical Application of Breast Cancer Organoids
Jin Seok Yu, Wei Huang · 2020 · International Journal of Stem Cells
Multifunctional Nanosystems with Enhanced Cellular Uptake for Tumor Therapy
Zhaoyu Ma, Mohamed F. Foda, Yanli Zhao, Heyou Han · 2021 · Advanced Healthcare Materials
Monitoring drug induced apoptosis and treatment sensitivity in non-small cell lung carcinoma using dielectrophoresis
Rajeshwari Taruvai Kalyana Kumar, Shanshan Liu, John Dorrance Minna, Shalini Prasad · 2016 · Biochimica et Biophysica Acta (BBA) - General Subjects
Oxidative stress downstream of mTORC1 but not AKT causes a proliferative defect in cancer cells resistant to PI3K inhibition
Maria Dermit, Pedro Casado, Vinothini Rajeeve, Edmund H. Wilkes, Daniel E. Foxler, Hayley Campbell, Susan E. Critchlow, Tyson V. Sharp, John G. Gribben, Robert John Unwin et al. · 2016 · Oncogene
Dual specificity phosphatase 5 is a novel prognostic indicator for patients with advanced colorectal cancer.
Xuebing Yan, Liguo Liu, Hao Li, Linsheng Huang, Mingming Yin, Cheng Pan, Huanlong Qin, Zhiming Jin · 2016 · PubMed Central
Spatiotemporal diversification of intrapatient genomic clones and early drug development concepts realize the roadmap of precision cancer medicine
Dimitrios H Roukos · 2017 · Drug Discovery Today
Comprehensive characterization of the phosphoproteome of gastric cancer from endoscopic biopsy specimens
Yuichi Abe, Hidekazu Hirano, Hirokazu Shoji, Asa Tada, Junko Isoyama, Akemi Kakudo, Daigo Gunji, Kazufumi Honda, Narikazu Boku, Jun Adachi et al. · 2020 · Theranostics
Defining precision health: a scoping review protocol
Jillian Claire Ryan, John Noel M. Viaña, Hamza Sellak, Shakuntla V. Gondalia, Nathan J. O’Callaghan · 2021 · BMJ Open
Supervised learning on impedance cytometry data for label-free biophysical distinction of pancreatic cancer cells versus their associated fibroblasts under gemcitabine treatment
Armita Salahi, Carlos Honrado, John Moore, Sara J. Adair, Todd W. Bauer, Nathan S. Swami · 2023 · Biosensors and Bioelectronics
Drug resistance: origins, evolution and characterization of genomic clones and the tumor ecosystem to optimize precise individualized therapy
Ioannis D Kyrochristos, Dimosthenis E. Ziogas, Dimitrios H Roukos · 2019 · Drug Discovery Today
Future directions in soft tissue sarcoma treatment
Francis Hall, Victor Manuel Villalobos, Breelyn Ann Wilky · 2019 · Current Problems in Cancer
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group ‘Molecular Diagnostics and Therapy’
Christoph Benedikt Westphalen, Carsten Bokemeyer, Reinhard Büttner, Stefan Fröhling, Verena I. Gaidzik, Hanno Glimm, Ulrich Thorsten Hacker, Volker Heinemann, Anna Lena Illert, Ulrich Keilholz et al. · 2020 · European Journal of Cancer
Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy
Yuya Yoshimoto, Yasushi Sasaki, Kazutoshi Murata, Shin‐ei Noda, Yuhei Miyasaka, Junko Hamamoto, Mio Furuya, Junko Hirato, Yoshiyuki Suzuki, Tatsuya Ohno et al. · 2020 · Gynecologic Oncology
Identification of RAS mutant biomarkers for EGFR inhibitor sensitivity using a systems biochemical approach
Thomas B. McFall, Edward C. Stites · 2021 · Cell Reports
Deep Morphology Learning Enhances <i>Ex Vivo</i> Drug Profiling-Based Precision Medicine
Heinemann, Tim, Kornauth, Christoph, Severin, Yannik, Vladimer, Gregory I., Pemovska, Tea, Hadzijusufovic, Emir, Agis, Hermine, Krauth, Maria-Theresa, Sperr, Wolfgang R., Valent, Peter et al. · 2022 · Blood Cancer Discovery
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients
Emma Åkerlund, Greta Gudoitytė, Elisabeth L. Moussaud-Lamodière, Olina Lind, Henri Colyn Bwanika, Kaisa Lehti, Sahar Salehi, Joseph W. Carlson, Emelie Wallin, Josefin Fernebro et al. · 2023 · npj Precision Oncology
Using Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer Therapy
José Ernesto Belizário, Beatriz A. Sangiuliano, Marcela Pérez-Sosa, Jennifer M. Neyra, Dayson Moreira · 2016 · Frontiers in Pharmacology
Prognostic scoring system for osteosarcoma using network‐regularized high‐dimensional Cox‐regression analysis and potential therapeutic targets
Tae Sik Goh, Jung Sub Lee, Jeung Il Kim, Yong Geon Park, Kyoungjune Pak, Dae Cheon Jeong, Sae‐Ock Oh, Yun Hak Kim · 2019 · Journal of Cellular Physiology